Mesenchymal-Stromal Cell-like Melanoma-Associated Fibroblasts Increase IL-10 Production by Macrophages in a Cyclooxygenase/Indoleamine 2,3-Dioxygenase-Dependent Manner.
Uğur ÇakırAnna HajdaraBalázs SzékyBalázs MayerSarolta KárpátiEva MezeyPálma SillóGergely SzakacsAndrás FürediZoltán PósBarbara ÉrsekMiklós SárdyKrisztián NémethPublished in: Cancers (2021)
Melanoma-associated fibroblasts (MAFs) are integral parts of melanoma, providing a protective network for melanoma cells. The phenotypical and functional similarities between MAFs and mesenchymal stromal cells (MSCs) prompted us to investigate if, similarly to MSCs, MAFs are capable of modulating macrophage functions. Using immunohistochemistry, we showed that MAFs and macrophages are in intimate contact within the tumor stroma. We then demonstrated that MAFs indeed are potent inducers of IL-10 production in various macrophage types in vitro, and this process is greatly augmented by the presence of treatment-naïve and chemotherapy-treated melanoma cells. MAFs derived from thick melanomas appear to be more immunosuppressive than those cultured from thin melanomas. The IL-10 increasing effect is mediated, at least in part, by cyclooxygenase and indoleamine 2,3-dioxygenase. Our data indicate that MAF-induced IL-10 production in macrophages may contribute to melanoma aggressiveness, and targeting the cyclooxygenase and indoleamine 2,3-dioxygenase pathways may abolish MAF-macrophage interactions.
Keyphrases
- bone marrow
- mesenchymal stem cells
- adipose tissue
- skin cancer
- nitric oxide synthase
- stem cells
- extracellular matrix
- electronic health record
- basal cell carcinoma
- cell therapy
- signaling pathway
- umbilical cord
- cancer therapy
- nitric oxide
- oxidative stress
- radiation therapy
- newly diagnosed
- drug induced
- deep learning
- combination therapy